Notably, the levels of TRA2B, SRSF9, and RBM3 were also associated with less recurrence or distant metastasis, suggesting that these splicing factors might have pathophysiological relevance in this tumor pathology and suggesting a causal link between dysregulation of these splicing factors and OSCC aggressiveness. This evidence concerns the gene TRA2B and neoplasm.